Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer

J B Arnes
February 2009
Journal of Clinical Pathology;Feb2009, Vol. 62 Issue 2, p139
Academic Journal
AIMS: BRCA1-related breast cancer is associated with a basal-like phenotype, and is frequently oestrogen receptor (ER) and HER2 negative. The expression of epidermal growth factor receptor (EGFR) has been considered to be one component of the basal-like phenotype, but no standard criteria exist. This study investigates the relationship between EGFR expression, BRCA1 status and basal markers with respect to clinicopathological associations and prognosis, in addition to evaluating different criteria for EGFR assessment by immunohistochemistry. METHODS: A tissue microarray comprising 230 available cases, from a series of primary invasive breast cancer diagnosed in Ashkenazi Jewish women during 1980–1995, was stained for EGFR using the Dako PharmDX kit, and evaluated by Webslide virtual microscopy. RESULTS: EGFR was positive in 9–19% according to different criteria. Expression was associated with BRCA1 carrier status and basal-like markers as negative ER, positive cytokeratin 5/6 and positive P-cadherin staining. EGFR was prognostically significant by univariate and multivariate analysis within the group carrying germ-line BRCA1 mutations. Histological grade, axillary lymph node status and P-cadherin status had significant independent value in the final multivariate model including all cases, whereas EGFR was not significant in this model. All five scoring systems gave comparable results concerning clinicopathological associations and patient outcome, although the most restrictive criteria (EGFR-HI) tended to be most sensitive in predicting BRCA1 status, a basal phenotype, and patient prognosis. CONCLUSIONS: EGFR expression, being present in 9–19% of the cases, was prognostically significant among BRCA1 mutated cases only. In multivariate survival analysis of all cases, no independent effect was seen. However, EGFR immunostaining might be relevant to predict the response to targeted therapy, and this should be studied further.


Related Articles

  • Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer. Wishart, Gordon C.; Rakha, Emad; Green, Andrew; Ellis, Ian; Ali, Hamid R.; Provenzano, Elena; Blows, Fiona M.; Caldas, Carlos; Pharoah, Paul D. P. // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background PREDICT (www.predict.nhs.uk) is a prognostication and treatment benefit tool for early breast cancer (EBC). The aim of this study was to incorporate the prognostic effect of KI67 status in a new version (v3), and compare performance with the Predict model that includes HER2 status...

  • Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptor-negative tumors and the prognosis of breast cancer: A meta-analysis. TAIYAN GUO; BOYUAN WANG; YINGZE HUANG; SHUTING JIA; WENRU TANG; YING LUO; YONGYONG REN // Molecular & Clinical Oncology;Nov/Dec2015, Vol. 3 Issue 6, p1353 

    Aberrant methylation of the breast cancer susceptibility gene 1 (BRCA1) promoter is a mechanism for its functional inactivation. It may potentially be used as a prognostic marker in studies for patients with breast cancer and plays an important role in tumorigenesis. Numerous studies have...

  • Molecular functions and significance of the MTA family in hormone-independent cancer. Ning, Zhifeng; Gan, Jinfeng; Chen, Chaoying; Zhang, Dianzheng; Zhang, Hao // Cancer & Metastasis Reviews;Dec2014, Vol. 33 Issue 4, p901 

    The members of the metastasis-associated protein (MTA) family play pivotal roles in both physiological and pathophysiological processes, especially in cancer development and metastasis, and their role as master regulators has come to light. Due to the fact that they were first identified as...

  • Epidermal growth factor receptor as a biomarker for cervical cancer. Soonthornthum, T.; Arias-Pulido, H.; Joste, N.; Lomo, L.; Muller, C.; Rutledge, T.; Verschraegen, C. // Annals of Oncology;Oct2011, Vol. 22 Issue 10, p2166 

    This review focuses on the different modes of expression of the epidermal growth factor receptor (EGFR). All methods used to assess EGFR expression are critically analyzed and insights into the use of inhibitors of EGFR for treatment of cervical cancer are discussed. Currently, expression of...

  • Is the Ki-67 labelling index ready for clinical use? Jonat, W.; Arnold, N. // Annals of Oncology;Mar2011, Vol. 22 Issue 3, p500 

    No abstract available.

  • Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. Rodríguez-Pinilla, Socorro María; Sarrió, David; Honrado, Emiliano; Moreno-Bueno, Gema; Hardisson, David; Calero, Francisco; Benitez, Javier; Palacios, José // Journal of Clinical Pathology;Sep2007, Vol. 60 Issue 9, p1006 

    Aims: To determine whether basal-like phenotype and vimentin and/or laminin are related in both sporadic/ familial (BRCA1 or BRCA2 mutated) tumours. Methods: 230 non-familial and 28 hereditary node-negative invasive breast carcinomas were immunohistochemically analysed for oestrogen receptors...

  • Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma. Chantzi, Νiki; Tiniakos, Dina; Palaiologou, Marina; Goutas, Nikolaos; Filippidis, Theodoros; Vassilaros, Stamatis; Dhimolea, Eugen; Mitsiou, Dimitra; Alexis, Μichael // Journal of Cancer Research & Clinical Oncology;Sep2013, Vol. 139 Issue 9, p1489 

    Purpose: Our aim was to examine the prognostic significance of ERbeta1 and ERbeta2 expression in ERalpha-negative breast carcinomas. Materials and methods: We evaluated nuclear and cytoplasmic expression of ERbeta1 and ERbeta2 by immunohistochemistry in a group of 95 patients with long...

  • Breast cancer: Untangling the role of progesterone receptors. Seton-Rogers, Sarah // Nature Reviews Cancer;Aug2015, Vol. 15 Issue 8, p456 

    The article focuses on the role of progesterone receptors (PR) in signalling in breast cancer. Topics discussed include use of PR as a marker of oestrogen receptor-α (ERα)-driven gene expression, expression of antiproliferative genes due to the changes in the pattern of ERα chromatin...

  • Clinicopathological study of centrally necrotizing carcinoma of the breast. Yanling Zhang; Yurong Ou; Donghong Yu; Xiang Yong; Xiaoli Wang; Bo Zhu; Qiong Zhang; Lei Zhou; Zhaogen Cai; Zenong Cheng // BMC Cancer;2015, Vol. 15 Issue 1, p1 

    Background: Centrally necrotizing carcinoma of the breast (CNC) represents a newly-identified subset of breast cancer. The clinical and pathological characteristics of this breast cancer subtype are not yet completely understood. Methods: We assessed the clinicopathological characteristics of 73...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics